Search for: "SANDOZ, INC."
Results 621 - 640
of 679
Sorted by Relevance
|
Sort by Date
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
13 Jun 2011, 12:10 pm
Sandoz, Inc., 699 F. [read post]
1 Aug 2023, 10:03 am
Sandoz, Inc., 678 F.3d 1280, 1294 (Fed. [read post]
6 Oct 2014, 5:36 am
Two different articles look ahead at next month’s oral argument in the securities case Omnicare, Inc. v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
2 Sep 2011, 4:27 am
Hoffmann–La Roche, Inc., 24 F.3d 463, 469 (3d Cir.1994). [read post]
5 Mar 2024, 10:55 am
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
1 Feb 2022, 4:08 pm
Civil enforcement actions against the parties responsible for triggering and fueling the opioid epidemic are a critical part of the department’s ongoing efforts to address this crisis.Consistent with this focus, the largest False Claims Act settlements in the past year resulted from significant resolutions with prescription opioid manufacturers: Indivior Inc. and Indivior plc (Indivior), and Purdue Pharma (Purdue). [read post]
10 Sep 2012, 7:28 pm
., Glaxo, Inc. v. [read post]
5 Jan 2010, 10:56 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition Brief in opposition for respondent Sandoz, Inc. [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
4 Nov 2018, 10:56 am
., Inc. v. [read post]
23 Apr 2014, 8:50 am
Sandoz, Inc., 13-854 (granted at the March 28 Conference, relisted twice); Jennings v. [read post]
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
5 Nov 2007, 12:58 pm
American Medical Systems, Inc., 958 F. [read post]
6 Jan 2021, 10:35 am
Sandoz Canada Inc., 2020 FC 1189 (CanLII), <http://canlii.ca/t/jcchv>. [read post]
23 Jul 2012, 2:33 pm
Sandoz, Inc., 566 F.3d 1282, 1288 (Fed. [read post]
13 Jun 2017, 4:45 am
’” Finally, in Amgen Inc. v. [read post]
